News
12h
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
1d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...
3d
Health and Me on MSNOzempic, Wegovy Aren't Magic, These 5 Body Traits Predict If You’ll Actually Lose WeightA new study reveals key predictors of successful weight loss on GLP-1RA drugs like Ozempic and Wegovy, including longer ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
7d
ZME Science on MSNOzempic Is Changing More Than Waistlines as Scientists Wise Up to Concerning Side EffectsAnimal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results